It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Psychotic symptoms are not only an important feature of severe neuropsychiatric disorders, but are also common in the general population, especially in youth. The genetic etiology of psychosis symptoms in youth remains poorly understood. To characterize genetic risk for psychosis spectrum symptoms (PS), we leverage a community-based multiethnic sample of children and adolescents aged 8–22 years, the Philadelphia Neurodevelopmental Cohort (n = 7225, 20% PS). Using an elastic net regression model, we aim to classify PS status using polygenic scores (PGS) based on a range of heritable psychiatric and brain-related traits in a multi-PGS model. We also perform univariate PGS associations and evaluate age-specific effects. The multi-PGS analyses do not improve prediction of PS status over univariate models, but reveal that the attention deficit hyperactivity disorder (ADHD) PGS is robustly and uniquely associated with PS (OR 1.12 (1.05, 1.18) P = 0.0003). This association is driven by subjects of European ancestry (OR = 1.23 (1.14, 1.34), P = 4.15 × 10−7) but is not observed in African American subjects (P = 0.65). We find a significant interaction of ADHD PGS with age (P = 0.01), with a stronger association in younger children. The association is independent of phenotypic overlap between ADHD and PS, not indirectly driven by substance use or childhood trauma, and appears to be specific to PS rather than reflecting general psychopathology in youth. In an independent sample, we replicate an increased ADHD PGS in 328 youth at clinical high risk for psychosis, compared to 216 unaffected controls (OR 1.06, CI(1.01, 1.11), P = 0.02). Our findings suggest that PS in youth may reflect a different genetic etiology than psychotic symptoms in adulthood, one more akin to ADHD, and shed light on how genetic risk can be investigated across early disease trajectories.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of California, Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
2 University of California, Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University Hospital Carl Gustav Carus, Technische Universität Dresden, Department of Psychiatry and Psychotherapy, Dresden, Germany (GRID:grid.19006.3e)
3 University of North Carolina, Department of Psychiatry, Chapel Hill, USA (GRID:grid.410711.2) (ISNI:0000 0001 1034 1720)
4 Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34); Broad Institute of MIT and Harvard, Program in Medical and Population Genetics, Cambridge, USA (GRID:grid.66859.34); Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
5 Hotchkiss Brain Institute, Department of Psychiatry, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697)
6 Department of Psychiatry, UCSD, San Diego, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)
7 Zucker Hillside Hospital, Department of Psychiatry, Long Island, USA (GRID:grid.440243.5) (ISNI:0000 0004 0453 5950)
8 UCSF, and SFVA Medical Center, Department of Psychiatry, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811)
9 Yale University, Department of Psychiatry, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
10 Harvard Medical School at Beth Israel Deaconess Medical Center, Department of Psychiatry, Boston, USA (GRID:grid.239395.7) (ISNI:0000 0000 9011 8547)
11 Emory University, Departments of Psychology and Psychiatry, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)
12 Yale University, Department of Psychology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
13 University of Pennsylvania School of Medicine and the Penn-CHOP Lifespan Brain Institute, Department of Psychiatry, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
14 University of California, Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California, Department of Psychology, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
15 University of California, Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California, Department of Human Genetics, David Geffen School of Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Erasmus University Medical Center, Department of Psychiatry, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)